Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
Fig 3
Prevalence of significant liver fibrosis (F2-3) and cirrhosis (F4) by NAFLD and NASH status.
* p < 0.05; ** p < 0.001. p-values refer to chi-square test between patients with NASH (third column) and those with NAFLD but without NASH (second column) or those with no NAFLD (first column) and are considered significant when < 0.05.